NAD+ Study Shows How the Supplement Slows the Aging Process in Werner Syndrome

A new study on NAD+ adds insight into the aging process and how this particular supplement assists the body in cleaning up aging cells. Researchers studied Werner Syndrome, a particularly difficult disease associated with accelerated aging. Patients with Werner Syndrome have early signs of aging, such as grey hair, wrinkled skin, increased incidence of cancer and type 2 diabetes. On average, they die at the age of 45. The underlying mechanisms of the disease are unknown and therefore, no treatment is yet available.

NAD+

In this new study in the journal Nature Communications, an international team of researchers from, among others, the University of Copenhagen and the National Institutes of Health in the United States, has come closer to a new way of attacking the disease. The researchers examined the process of mitophagy, which breaks down defective mitochondria and reuses the proteins that they are made up of.

‘We are showing for the first time that Werner Syndrome is due to errors in the clean-up process. When we improve the clean-up by giving supplements of the drug NAD+, we can show in animal models that it increases lifespan and delays the aging processes’, says Professor Vilhelm Bohr from the Center for Healthy Aging, the University of Copenhagen, and the National Institutes of Health, who had led the study.

The researchers have looked closely at the clean-up processes in blood samples from patients with Werner Syndrome, in banana flies and in roundworms with the syndrome. They have also tested NAD+ in the animal models.

‘It strongly reinforces our findings that the clean-up process seems to be important in both human cells and across different animals. And then it is encouraging that in living animals, we can improve lifespan and delay the aging processes which are the key symptoms of Werner Syndrome’, says Vilhelm Bohr.

Werner Syndrome is most common in Japan, where between 1 in 20,000 and 1 in 40,000 people suffer from the disease. In the United States, it is 1 in 200,000.

‘Our results are so promising that we have received inquiries from Japan with a view to performing clinical studies of patients with Werner Syndrome. We very much hope that the studies will point in the same direction so that patients can live longer and with a higher quality of life’, says Professor Vilhelm Bohr.

The study also helps to understand the mechanisms of aging, as aging processes in patients with Werner Syndrome are similar to what you normally see, except that the aging happens significantly earlier. In the long term, the new knowledge can therefore also help to delay the normal aging of the body and improve the quality of life in old age.

Conclusion/ The researchers concluded: “At the organismal level, NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in Caenorhabditis elegans and Drosophila melanogaster models of WS. Our findings suggest that accelerated aging in WS is mediated by impaired mitochondrial function and mitophagy, and that bolstering cellular NAD+ levels counteracts WS phenotypes.”

Source: Fang, E.F., Hou, Y., Lautrup, S. et al. NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome. Nat Commun10, 5284 (2019) doi:10.1038/s41467-019-13172-8